Covered recipient · General Payments record
DEVORAH R SHAGALOV
Allopathic & Osteopathic Physicians Dermatology
General Payments · PY2018–2024
$2,346.27
- Reported across 71 records
- CMS publication 2026-01-23
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How these totals are calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
PY2024 · sorted by reported total
| Nature of payment | Amount | Records |
|---|---|---|
| Food and Beverage | $811.03 | 26 |
By paying entity
PY2024 · sorted by reported total
| Paying entity | Amount | Records |
|---|---|---|
| ABBVIE INC. | $360.86 | 12 |
| Dermavant Sciences, Inc. | $135.55 | 2 |
| GENZYME CORPORATION | $66.71 | 2 |
| PFIZER INC. | $44.35 | 2 |
| Regeneron Healthcare Solutions, Inc. | $37.86 | 1 |
| Kerecis Limited | $32.24 | 1 |
| NOVARTIS PHARMACEUTICALS CORPORATION | $30.85 | 1 |
| STRATA Skin Sciences, Inc. | $30.53 | 2 |
| MERZ NORTH AMERICA, INC. | $28.33 | 1 |
| Incyte Corporation | $27.36 | 1 |
| Biofrontera Inc. | $16.39 | 1 |
By program year
All program years on this page · sorted by year
Payment records · PY2024 (26)
Sorted by paying entity, then date · as published by CMS
Program year 2024 201820192020202120222023
Record-level detail is published for PY2024; earlier years are summarised in
“By program year”.
| Paying entity | Amount | Date | Nature of payment | Dispute status | Published | Record ID | Source |
|---|---|---|---|---|---|---|---|
| ABBVIE INC. | $9.88 | 01/04/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1106062216 | CMS |
| ABBVIE INC. | $16.77 | 01/04/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1106062218 | CMS |
| ABBVIE INC. | $10.00 | 01/26/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1106062220 | CMS |
| ABBVIE INC. | $5.83 | 04/11/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1106062222 | CMS |
| ABBVIE INC. | $128.91 | 04/17/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1106062224 | CMS |
| ABBVIE INC. | $32.23 | 06/04/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1106062226 | CMS |
| ABBVIE INC. | $32.23 | 06/04/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1106062228 | CMS |
| ABBVIE INC. | $31.25 | 06/20/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1106062230 | CMS |
| ABBVIE INC. | $31.25 | 06/20/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1106062232 | CMS |
| ABBVIE INC. | $27.88 | 06/26/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1106062234 | CMS |
| ABBVIE INC. | $9.47 | 08/21/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1106062236 | CMS |
| ABBVIE INC. | $25.16 | 09/10/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1106062238 | CMS |
| Biofrontera Inc. | $16.39 | 11/13/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1108518456 | CMS |
| Dermavant Sciences, Inc. | $113.82 | 03/19/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1127931615 | CMS |
| Dermavant Sciences, Inc. | $21.73 | 04/18/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1127931618 | CMS |
| GENZYME CORPORATION | $38.53 | 05/13/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1139904479 | CMS |
| GENZYME CORPORATION | $28.18 | 07/08/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1139904495 | CMS |
| Incyte Corporation | $27.36 | 07/22/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1141230841 | CMS |
| Kerecis Limited | $32.24 | 02/02/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1120093331 | CMS |
| MERZ NORTH AMERICA, INC. | $28.33 | 12/11/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1146369223 | CMS |
| Novartis Pharmaceuticals Corporation | $30.85 | 10/28/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1087169905 | CMS |
| PFIZER INC. | $23.38 | 02/25/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1131560388 | CMS |
| PFIZER INC. | $20.97 | 08/26/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1131850467 | CMS |
| Regeneron Healthcare Solutions, Inc. | $37.86 | 05/07/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1114167328 | CMS |
| STRATA Skin Sciences, Inc. | $14.34 | 07/15/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1146583233 | CMS |
| STRATA Skin Sciences, Inc. | $16.19 | 08/14/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1146583235 | CMS |
Source & provenance
- Dataset
- CMS Open Payments — General Payments
- Publisher of source data
- Centers for Medicare & Medicaid Services
- CMS publication date
- 2026-01-23
- Program years on this page
- 2018, 2019, 2020, 2021, 2022, 2023, 2024
- Source files
- Dataset page · Bulk file · PY2018 , PY2019 , PY2020 , PY2021 , PY2022 , PY2023 , PY2024
- Generated from
- OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.